Frekil
Frekil offers an AI-driven platform that automates the generation of real-world evidence from electronic health records and claims data, enabling rapid hypothesis testing and study execution. The technology includes features for cohort selection, statistical analysis plan drafting, and the production of publication-ready results, all while ensuring data security through a sandbox execution environment.
- Location: San Francisco, California, United States
- Founded: 2024-01-01
- Total funding: 500000
- Website: https://frekil.com
Product & Features
- Frekil rapidly generates real-world evidence using a self-improving AI engine.
- It automates the entire epidemiological workflow, from data to publication-ready evidence.
- Users interact with data and refine study steps using conversational interfaces.
- The platform connects and harmonizes EHR, claims, and registry data for comprehensive analysis.
- Frekil ensures data privacy by separating AI models from sensitive patient records.
- It supports diverse RWE use cases, including safety, label expansion, and trial feasibility.
- The system generates transparent and auditable statistical code in R, Python, and SAS.
- It understands complex medical ontologies and resolves clinical synonyms automatically.
Similar Companies
Frequently Asked Questions
What is Frekil?
Frekil offers an AI-driven platform that automates the generation of real-world evidence from electronic health records and claims data, enabling rapid hypothesis testing and study execution. The technology includes features for cohort selection, statistical analysis plan drafting, and the…
What does Frekil do?
Frekil rapidly generates real-world evidence using a self-improving AI engine. It automates the entire epidemiological workflow, from data to publication-ready evidence. Users interact with data and refine study steps using conversational interfaces.
Where is Frekil based?
Frekil is based in San Francisco, California, United States.
When was Frekil founded?
Frekil was founded in 2024.